Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max S Wicha

Showing results (151-160 of 209) with videos related to

Pageof 21
Sort By:
Cancer Research|December 18, 2019
Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease MetastasisShasha Ruan, Ming Lin, Yong Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2018
Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid CarcinomaApril Andrews, Kristy Warner, Christie Rodriguez-Ramirez, et al.
Biomaterials|July 25, 2016
Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapyHayley J Paholak, Nicholas O Stevers, Hongwei Chen, et al.
Cancer Research|January 13, 2011
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networksSuling Liu, Christophe Ginestier, Sing J Ou, et al.
Oncoimmunology|May 8, 2015
Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cellsLin Lu, Huimin Tao, Alfred E Chang, et al.
Cell Systems|September 25, 2017
High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor CellsEric Lin, Lianette Rivera-Báez, Shamileh Fouladdel, et al.
Cancer Research|September 12, 2024
Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox CyclingMing Luo, Na Shen, Li Shang, et al.
Cell Stem Cell|March 29, 2008
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeChristophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, et al.
Breast Cancer Research and Treatment|September 3, 2021
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)Lori J Goldstein, Mauro Mansutti, Christelle Levy, et al.
Neoplasia (New York, N.Y.)|May 31, 2016
IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor RecurrenceKelsey A Finkel, Kristy A Warner, Samuel Kerk, et al.
Pageof 21

Showing results (151-160 of 209) with videos related to

Sort By:
Pageof 21
Cancer Research|December 18, 2019
Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease MetastasisShasha Ruan, Ming Lin, Yong Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2018
Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid CarcinomaApril Andrews, Kristy Warner, Christie Rodriguez-Ramirez, et al.
Biomaterials|July 25, 2016
Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapyHayley J Paholak, Nicholas O Stevers, Hongwei Chen, et al.
Cancer Research|January 13, 2011
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networksSuling Liu, Christophe Ginestier, Sing J Ou, et al.
Oncoimmunology|May 8, 2015
Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cellsLin Lu, Huimin Tao, Alfred E Chang, et al.
Cell Systems|September 25, 2017
High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor CellsEric Lin, Lianette Rivera-Báez, Shamileh Fouladdel, et al.
Cancer Research|September 12, 2024
Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox CyclingMing Luo, Na Shen, Li Shang, et al.
Cell Stem Cell|March 29, 2008
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeChristophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, et al.
Breast Cancer Research and Treatment|September 3, 2021
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)Lori J Goldstein, Mauro Mansutti, Christelle Levy, et al.
Neoplasia (New York, N.Y.)|May 31, 2016
IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor RecurrenceKelsey A Finkel, Kristy A Warner, Samuel Kerk, et al.
Pageof 21